Skip to main content
Netherlands News in English

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Protester demanding the release of the Epstein files at a rally in Atlanta, United States. 1 September 2025
Protester demanding the release of the Epstein files at a rally in Atlanta, United States. 1 September 2025 - Credit: BluIz60 / DepositPhotos - License: DepositPhotos
Business
Epstein files
misogyny
Adriaan Tuiten
Emotional Bruin
libido pill
Jeffrey Epstein
Donald Rubin
Arletta Pharma Solutions
Marcel Wijma
Thursday, 5 February 2026 - 08:36

Share this article:

Dutch inventor of arousal pill for women approached Epstein to be an investor

The Dutch inventor of the female libido pill, Adriaan Tuiten, unsuccessfully approached Jeffrey Epstein to be an investor in his project, the Volkskrant reports from the Epstein files.

This happened in December 2016, eight years after Epstein’s first conviction for sex crimes against a child. Scientist Tuiten, convinced that his female equivalent of Viagra would make him an instant success, approached the convicted sex offender with his “strictly confidential” plans for his company, Emotional Brain.

Tuiten came into contact with Epstein through Donald Rubin, a professor of statistics at Harvard University who served on Emotional Brain’s scientific advisory board. Tuiten sent a detailed “pitch deck” in which he described the libido pills and projections that they could earn billions in the long run.

Epstein replied that “the deck is really bad,” speaking of a poor and vague presentation. “All very goofy.” He said Rubin was just a professor they paid to convince a bunch of idiots that this product would work. “I’m out, sorry.”

The Volkskrant couldn’t reach Tuiten for a comment. He was bought out of Emotional Brain four years ago by a group of new investors led by Marcel Wijma after the launch of his libido pills failed miserably, according to the newspaper.

Wijma relaunched Emotional Brain as Arletta Pharma Solutions in December 2025. The name change was to “sound much more female-friendly,” Wijma told the Volkskrant. The company is currently testing its libido pill and is hopeful about the results.

Wijma called the attempt to enlist Epstein as an investor “very desperate of Tuiten” and said he did not know about it. “We want to help women,” Wijma told the Volkskrant. “And then you shouldn’t get involved with those kinds of people.”

More like this

Image
Protester demanding the release of the Epstein files at a rally in Atlanta, United States. 1 September 2025
Epstein files: "Recruiter" approached at least 5 Dutch models for sex crime convict
Image
Sarah Ransome featured in the 2021 documentary series, Jeffrey Epstein: Filthy Rich
Epstein whistleblower Sarah Ransome received €1 million settlement; Living in Friesland
Image
US Consulate General in Amsterdam Museumplein
Alleged Jeffrey Epstein victim came forward at U.S. consulate in Amsterdam
Image
Protester demanding the release of the Epstein files at a rally in Atlanta, United States. 1 September 2025
Dutch model Sylvia Geersen also mentioned in the Epstein files
Make NL Times your top Google source

Follow us:

Latest stories

  • Netherlands joins call to curb Russian tourist travel to Europe
  • Oranje departs for United States as FIFA World Cup countdown begins
  • Men drugging, raping wives & girlfriends on camera is "next level" criminality: Police
  • Video: Suspected tornado whips through village near Enschede, damaging homes
  • European Sleeper drops Amsterdam from Milan night train plan, adds Breda, Eindhoven

Top stories

  • Video: Suspected tornado whips through village near Enschede, damaging homes
  • Dutch companies imported €2 billion worth of dangerous designer drugs from India
  • Rate of birth complications higher in poorer neighborhoods
  • At least 8 Dutch men suspected of drugging, raping, filming their wives, girlfriends
  • Court rules Ye can remain in Netherlands for Arnhem performances this week

© 2012-2026, NL Times, All rights reserved.

Footer menu

  • Change Privacy Settings
  • Privacy Policy
  • Contact
  • Partner Content